Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of cancer stem cell activity by thyroid hormone receptor β. | Oncogene | 2022 | 35256781 | PubTator, text mining | PubMed |
| Association of ALDH1 with Response to Radiotherapy and Its Impact on Survival in Patients with Advanced Stage of Head and Neck Squamous Cell Carcinoma (HNSCC). | Asian Pac J Cancer Prev | 2022 | 35225452 | PubTator, text mining | PubMed |
| Zika Virus Infection of Sertoli Cells Alters Protein Expression Involved in Activated Immune and Antiviral Response Pathways, Carbohydrate Metabolism and Cardiovascular Disease. | Viruses | 2022 | 35215967 | PubTator, text mining | PubMed |
| Evidence of depot-specific regulation of all-trans-retinoic acid biosynthesis in human adipose tissue. | Clin Transl Sci | 2022 | 35213790 | PubTator, text mining | PubMed |
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. | J Med Chem | 2022 | 35212533 | PubTator, text mining | PubMed |
| Protein Degradation by E3 Ubiquitin Ligases in Cancer Stem Cells. | Cancers (Basel) | 2022 | 35205738 | PubTator, text mining | PubMed |
| Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection. | Genes (Basel) | 2022 | 35205318 | PubTator, text mining | PubMed |
| FAM83A is a potential biomarker for breast cancer initiation. | Biomark Res | 2022 | 35183258 | PubTator, text mining | PubMed |
| Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53. | Biomed Res Int | 2022 | 35178443 | PubTator, text mining | PubMed |
| Action and Interaction between Retinoic Acid Signaling and Blood-Testis Barrier Function in the Spermatogenesis Cycle. | Cells | 2022 | 35159162 | PubTator, text mining | PubMed |
| Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity. | Clin Pharmacol Ther | 2022 | 35158408 | PubTator, text mining | PubMed |
| LncRNAs, the Molecules Involved in Communications With Colorectal Cancer Stem Cells. | Front Oncol | 2022 | 35155247 | PubTator, text mining | PubMed |
| α-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer. | Theranostics | 2022 | 35154481 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors. | ACS Omega | 2022 | 35128241 | PubTator, text mining | PubMed |
| MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. | Oncoimmunology | 2022 | 35127252 | PubTator, text mining | PubMed |
| Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells. | Cancer Immunol Immunother | 2022 | 35098344 | PubTator, text mining | PubMed |
| The tyrosine kinase inhibitor LPM4870108 impairs learning and memory and induces transcriptomic and gene‑specific DNA methylation changes in rats. | Arch Toxicol | 2022 | 35098321 | PubTator, text mining | PubMed |
| Redox Metabolism-Associated Molecular Classification of Clear Cell Renal Cell Carcinoma. | Oxid Med Cell Longev | 2022 | 35096270 | PubTator, text mining | PubMed |
| Triple-negative expression (ALDH1A1-/CD133-/mutant p53-) cases in lung adenocarcinoma had a good prognosis. | Sci Rep | 2022 | 35087112 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=27